Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083606

Options or other derivatives

  • Chief Commercial Officer acquired 16,385 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Maizel Ari Chief Commercial Officer 2026-02-26 Grant or award · Restricted Stock Units +16,385 16,385 D
Loading xslF345X05/ownership.xml…